Cardiovascular Business December 12, 2024
Dave Fornell

The United States spends more on healthcare than any other nation, but continues to see poor outcomes, according to U.S. Food and Drug Administration (FDA) Commissioner Robert Califf, MD. Speaking at the Transcatheter Cardiovascular Therapeutics (TCT) 2024 meeting on the topic, Califf emphasized the urgent need for systemic reform in the nation’s approach to healthcare. He listed rising infant mortality rates and declining life expectancy as two significant indicators of a broader crisis.

Califf, a cardiologist who previously served as a professor of cardiology at Duke University School of Medicine and was the founding director of the Duke Clinical Research Institute, pointed out that the U.S. lags behind other high-income nations in key health metrics despite its advanced technology and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: FDA, Govt Agencies, Healthcare System
Related Articles:
FDA Clears Withings’ New Blood Pressure Monitor That Allows Providers to Communicate Directly with Patients
4 takeaways from the FDA’s first digital health advisory committee
FDA commissioner urges health systems to strengthen AI quality oversight
Diversity data in the US: Understanding the FDA’s push for more representation in clinical trials
AI's future at the FDA

Share This Article